Medical specialist practice in FR. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2021. This is not a current market value or asking price.
Based on filed company accountsThe historical curve shows where this company stood. Unlock what holds back value today, what it could be in five years and which actions matter now.
Free account · private workspace
Public filings are a starting point. Accounts, owner context and method review narrow the range and make it useful for a sale, financing or transfer.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for Docteur Jean-Marc GARZON uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Docteur Jean-Marc GARZON is a medical specialist practice based in France. The company was founded in 2003, incorporated as a 5485.
Docteur Jean-Marc GARZON is listed in French National Business Register (RNE/INPI) under registry number 448516039. The public employee band is 01, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Within the French NACE 86.22 cluster, public-record data is filed annually via the national company registry.
The most recently filed revenue (2021) stands at €1,208,832.
The most recent annual filing covers 2021 (period end 2021-12-31).
If you are researching Docteur Jean-Marc GARZON for acquisition, investment, or due-diligence purposes, this page consolidates its firmographics, multi-year filings, and a historical indicative range based on the latest available public filing, not a current market value.
Public regulator-filed figures across 4 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202131 Dec 2021 | €1,208,832 | - | €712,516 | €608,897 | - |
| 201931 Dec 2019 | - | - | €666,346 | €427,092 | - |
| 201731 Dec 2017 | €1,018,428 | - | €535,770 | €459,587 | - |
| 201631 Dec 2016 | - | - | €586,462 | €460,393 | - |
Docteur Jean-Marc GARZON was founded in 2003 and is registered with French National Business Register (RNE/INPI), incorporated as a 5485.
Docteur Jean-Marc GARZON is registered under NACE 86.22: NACE 86.22. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2021 (period end 2021-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows a rounded historical indicative range for Docteur Jean-Marc GARZON, based on the latest available public filing for fiscal year 2021. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
